Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>In vitro</i> antibacterial activity of gepotidacin in combination with other antimicrobial agents against <i>Neisseria gonorrhoeae</i> isolates.

Antimicrobial agents and chemotherapy·2026
Same author

Influence of different media and incubation times for determining the minimum inhibitory concentrations of gepotidacin, ciprofloxacin and ceftriaxone against Neisseria gonorrhoeae.

Diagnostic microbiology and infectious disease·2026
Same author

Author Correction: Phage therapy with nebulized cocktail BX004-A for chronic Pseudomonas aeruginosa infections in cystic fibrosis: a randomized first-in-human trial.

Nature communications·2026
Same author

Development of a rezafungin isolate verification panel and comparison of reference method to ThermoFisher Sensititre YeastOne panel MIC results.

Diagnostic microbiology and infectious disease·2025
Same author

Establishing the reference broth microdilution MIC method for cefepime-taniborbactam.

Journal of clinical microbiology·2025
Same author

Phage therapy with nebulized cocktail BX004-A for chronic Pseudomonas aeruginosa infections in cystic fibrosis: a randomized first-in-human trial.

Nature communications·2025

Related Experiment Video

Updated: Jun 28, 2026

One-day Workflow Scheme for Bacterial Pathogen Detection and Antimicrobial Resistance Testing from Blood Cultures
08:30

One-day Workflow Scheme for Bacterial Pathogen Detection and Antimicrobial Resistance Testing from Blood Cultures

Published on: July 9, 2012

25.6K

Sulopenem Disk Development, Quality Control Range, and MIC to Disk Result Correlation for Enterobacterales Isolates.

Sailaja Puttagunta1, Steven I Aronin1, Jeanna DiFranco-Fisher2

  • 1Iterum Therapeutics, Old Saybrook, Connecticut, USA.

Journal of Clinical Microbiology
|June 26, 2023
PubMed
Summary

The 2-μg sulopenem disk demonstrates accurate and reproducible performance for antimicrobial susceptibility testing of Enterobacterales. This antibiotic susceptibility testing method showed minimal errors and reliable quality control results.

Keywords:
antibacterial agentantimicrobial susceptibility testingdisk diffusionsulopenemsusceptibility

More Related Videos

A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically
11:28

A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically

Published on: September 9, 2015

29.1K
Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

26.3K

Related Experiment Videos

Last Updated: Jun 28, 2026

One-day Workflow Scheme for Bacterial Pathogen Detection and Antimicrobial Resistance Testing from Blood Cultures
08:30

One-day Workflow Scheme for Bacterial Pathogen Detection and Antimicrobial Resistance Testing from Blood Cultures

Published on: July 9, 2012

25.6K
A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically
11:28

A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically

Published on: September 9, 2015

29.1K
Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

26.3K

Area of Science:

  • Microbiology
  • Clinical Pharmacy
  • Infectious Diseases

Background:

  • Sulopenem is a novel carbapenem antibiotic.
  • Accurate antimicrobial susceptibility testing (AST) is crucial for guiding treatment decisions.
  • Standardized methods for sulopenem AST are needed.

Purpose of the Study:

  • To evaluate the performance of sulopenem disk diffusion for AST.
  • To establish quality control (QC) parameters for sulopenem disk diffusion.

Main Methods:

  • Disk diffusion and broth microdilution methods were used.
  • Error-rate bounding analysis was performed according to CLSI guideline M23.
  • An eight-laboratory quality control study was conducted.

Main Results:

  • The 2-μg sulopenem disk showed high accuracy with very few interpretive errors among 2,856 Enterobacterales isolates.
  • Quality control testing demonstrated 99.0% of results within the acceptable range (24-30 mm).
  • A CLSI-established QC range for Escherichia coli 29522 was determined (24-30 mm).

Conclusions:

  • The 2-μg sulopenem disk is a reliable method for AST of Enterobacterales.
  • The established QC range ensures consistent and accurate testing.
  • This method supports effective sulopenem utilization in clinical settings.